Hydroquinidine therapy in Brugada syndrome

Journal of the American College of Cardiology

Volumn 43, Issue 10, 2004, Pages 1853-1860

  Hermida, Jean Sylvain ^a   Denjoy, Isabelle ^b,c   Clerc, Jérôme ^a   Extramiana, Fabrice ^b   Jarry, Geneviève ^a   Milliez, Paul ^b   Guicheney, Pascale ^c   Di Fusco, Stefania ^b   Rey, Jean Luc ^a   Cauchemez, Bruno ^b   Leenhardt, Antoine ^b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

BrS; Brugada syndrome; ECG; electrocardiogram; electrophysiologic; EP; HQ; hydroquinidine; Ito; ICD; implantable cardioverter defibrillator; transient outward current; ventricular fibrillation; ventricular tachycardia; VF; VT

Indexed keywords

DIHYDROQUINIDINE;

ADULT; AGED; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEFIBRILLATOR; DIARRHEA; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROSTIMULATION THERAPY; FEMALE; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEPATITIS; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QT PROLONGATION; RECURRENT DISEASE; SLOW DRUG RELEASE; SYMPTOMATOLOGY; SYNCOPE; TACHYCARDIA;

ADOLESCENT; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; QUINIDINE; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 2442495365     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.12.046     Document Type: Article

References (24)

1. Brugada P., Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death A distinct clinical and electrocardiographic syndrome. a multicenter report. J Am Coll Cardiol. 20:1992;1391-1396
2. Antzelevitch C. The Brugada syndrome Diagnostic criteria and cellular mechanisms. Eur Heart J. 22:2001;356-363
3. Yan G.X., Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 100:1999;1660-1666
4. 3 and sudden cardiac death: a marker for sudden death in patients without demonstrable structural heart disease. Circulation. 97:1998;457-460
5. 3. Circulation. 105:2002;73-78
6. Brugada P., Brugada R., Mont L., Rivero M., Geelen P., Brugada J. Natural history of Brugada syndrome The prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol. 14:2003;455-457
7. Nademanee K. Prognostic value of electrophysiologic studies in Brugada syndrome. J Am Coll Cardiol. 39:2002;1806-1807
8. Priori S.G., Napolitano C., Gasparini M., et al. Natural history of Brugada syndrome Insights for risk stratification and management. Circulation. 105:2002;1342-1347
9. Kanda M., Shimizu W., Matsuo K., et al. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol. 39:2002;1799-1805
10. Wilde A.A., Antzelevitch C., Borggrefe M., et al. Proposed diagnostic criteria for the Brugada syndrome Consensus report. Circulation. 106:2002;2514-2519
11. Belhassen B., Viskin S., Fish R., Glick A., Setbon I., Eldar M. Effects of electrophysiologic-guided therapy with class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol. 10:1999;1301-1312
12. Suzuki H., Torigoe K., Numata O., Yazaki S. Infant case with a malignant form of Brugada syndrome. J Cardiovasc Electrophysiol. 11:2000;1277-1280
13. Garg A., Finneran W., Feld G. Familial sudden cardiac death associated with a terminal QRS abnormality on surface 12-lead electrocardiogram in the index case. J Cardiovasc Electrophysiol. 9:1998;642-647
14. Alings M., Dekker L., Sadee A., Wilde A. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol. 24:2001;1420-1422
15. Shimizu W., Aiba T., Kurita T., Kamakura S. Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST-segment elevation. J Cardiovasc Electrophysiol. 12:2001;1418-1421
16. Priori S.G., Napolitano C., Gasparini M., et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome A prospective evaluation of 52 families. Circulation. 102:2000;2509-2515
17. Takenaka S., Kusano K.F., Hisamatsu K., et al. Relatively benign clinical course in asymptomatic patients with Brugada-type electrocardiogram without family history of sudden death. J Cardiovasc Electrophysiol. 12:2001;2-6
18. Eckardt L., Kirchhof P., Schullze-Bahr E., et al. Electrophysiologic investigation in Brugada syndrome Yield of programmed stimulation at two sites with up to three premature beats. Eur Heart J. 23:2002;1394-1401
19. Gasparini M., Priori S.G., Mantica M., et al. Programmed electrical stimulation in Brugada syndrome How reproducible are the results? J Cardiovasc Electrophysiol. 13:2002;880-887
20. Belhassen B., Viskin S., Antzelevitch C. The Brugada syndrome Is an implantable cardioverter defibrillator the only therapeutic option. Pacing Clin Electrophysiol. 25:2002;1634-1640
21. Tsuchiya T., Ashikaga K., Honda T., Arita M. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol. 13:2002;698-701
22. Nademanee K., Veerakul G., Mower M., et al. Defibrillator versus Beta-blockers for Unexplained death in Thailand (DEBUT) A randomized clinical trial. Circulation. 107:2003;2221-2226
23. Bezzina C., Veldkamp M.W., van Den Berg M.P., et al. A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res. 85:1999;1206-1213
24. Chinushi M., Aizawa Y., Ogawa Y., Shiba M., Takahashi K. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome. J Electrocardiol. 30:1997;133-136